Table 2.
Assessment Periods | p-values | |||||||
---|---|---|---|---|---|---|---|---|
Treatment Group | Baseline | 4 months | 1 year | 2 years | Treatment Group | Time | Treatment Group x Time | |
≥250 min/week of bout-related MVPA | Control | 81 (40.3%) | 83 (43.2%) | 65 (40.0%) | 63 (41.5%) | 0.2949 | 0.4872 | 0.1460 |
Small Change | 74 (37.2%) | 82 (45.6%) | 67 (44.7%) | 56 (37.6%) | ||||
Large Change | 88 (45.1%) | 98 (55.4%) | 65 (40.9%) | 71 (46.7%) | ||||
Increase daily steps by ≥2000 steps/day | Control | – | 32 (16.7%) | 25 (15.3%) | 31 (20.4%) | 0.1859 | 0.5124 | 0.8087 |
Small Change | – | 44 (24.4%) | 39 (26.0%) | 34 (22.8%) | ||||
Large Change | – | 40 (22.6%) | 35 (22.0%) | 32 (21.1%) |
N (%); Models adjusted for clinic, gender, race, armband wear time, and baseline value of outcome measure